Bioequivalence Waivers: When the FDA Allows In Vitro Testing Instead of Human Studies
The FDA allows bioequivalence waivers for certain generic drugs, skipping human studies when in vitro dissolution tests prove the drug performs the same. Learn how BCS classification makes this possible and why it saves time and money.
24 Dec 2025